← SynDRA
endo.IWR.1
SynDRA canonical compound SYN1970441 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | TNKS |
| Mechanism of action | WNT signaling inhibitor negative control |
All known targets
Mechanisms of action (all sources)
- WNT signaling inhibitor negative control
Cross-references
Synonyms
- IWR-1 endo
- IWR-1
- endo-IWR 1
- CHEBI:62882
- CHEMBL562310
- 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(quinolin-8-yl)benzamide
- rel-4-((3aR,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-yl)benzamide
- exo-IWR 1
- 4tkf
- 4-((3aR,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-yl)benzamide
- IWR1-endo
- IRW1
- SCHEMBL15315470
- EX-A642
- BCP05700
- ZINC2483738
- BDBM50007583
- MFCD18086875
- NSC756646
- CCG-208104
- NSC-756646
- IWR-1, >=98% (HPLC)
- AC-35923
- HY-12238
- rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide
- C71420
- BRD-K61314889-001-01-0
- Q27132252
- 4-[(1R,2S,6R,7S)-3,5-dioxo-4-azatricyclo[5.2.1.0{2,6}]dec-8-en-4-yl]-N-(quinolin-8-yl)benzamide
- 4-[(1S,2R,6S,7R)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]-N-quinolin-8-ylbenzamide
- Benzamide, 4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-
Look up endo.IWR.1 in the interactive SynDRA portal →